Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex Differences in the Vascular Effects of E-cigarette Use
NCT06159608Phase 1Recruiting
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms). Primary endpoints: Change in microvascular endothelium-dependent dilation response at 4 hours and Monthly estrogen exposure at 1 month. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06159608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06159608.